A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease
Recruiting
Observational Study
Alzheimer Disease
Gut Microbiota
Metabonomics
Magnetic Resonance Imaging
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 285 (estimated)
- Sponsor
- Jining Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Gut microbiota dysfunction is associated with Alzheimer's disease (AD). However, the potential modulatory mechanism remains unclear. Previous studies have shown that gut-derived metabolites short-chain fatty acids (SCFAs) may be the key mediators between gut microbiota and brain, participating in the modulatory pathway "gut microbiota-SCFAs-brain networks". In this project, high-throughput targete…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Cognitively normal group:
1. normal performance on standardized cognitive tests;
2. with no cognitive complaints or any concerns (worries).
* SCD group:
1. self-experienced persistent decline in memory, rather than other domains of cognition;
2. normal performance on…
Contacts